Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 173.03B | 176.77B | 172.66B | 141.32B | 110.91B | 99.79B |
Gross Profit | 74.44B | 75.74B | 75.12B | 59.38B | 46.53B | 41.18B |
EBITDA | 45.09B | 47.50B | 44.85B | 36.82B | 29.27B | 24.41B |
Net Income | 28.09B | 29.78B | 28.04B | 23.48B | 18.13B | 14.78B |
Balance Sheet | ||||||
Total Assets | 198.91B | 208.54B | 182.68B | 172.30B | 136.68B | 113.37B |
Cash, Cash Equivalents and Short-Term Investments | 20.96B | 19.33B | 11.22B | 11.85B | 19.58B | 11.65B |
Total Debt | 0.00 | 34.71B | 32.71B | 36.30B | 24.85B | 24.63B |
Total Liabilities | 98.20B | 94.78B | 91.18B | 92.28B | 69.05B | 59.83B |
Stockholders Equity | 100.65B | 113.70B | 91.45B | 79.98B | 67.63B | 53.22B |
Cash Flow | ||||||
Free Cash Flow | 29.68B | 30.86B | 22.63B | 16.35B | 19.79B | 19.41B |
Operating Cash Flow | 36.38B | 36.89B | 28.08B | 21.38B | 23.15B | 22.20B |
Investing Cash Flow | -12.90B | -13.32B | -9.39B | -15.50B | -6.12B | -16.29B |
Financing Cash Flow | -16.20B | -15.86B | -18.28B | -14.65B | -10.32B | -8.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $91.35B | 27.68 | 27.16% | 0.94% | -0.23% | 22.41% | |
76 Outperform | $139.48B | 35.86 | 20.76% | 1.04% | 7.66% | 9.19% | |
74 Outperform | $71.30B | 27.25 | 27.30% | 1.93% | 0.18% | 1.44% | |
73 Outperform | $57.89B | 37.80 | 8.15% | 0.59% | 13.59% | 6.52% | |
73 Outperform | $74.64B | 22.47 | 109.06% | 2.38% | -1.40% | 11.65% | |
71 Outperform | $79.07B | 33.55 | 10.86% | 1.50% | 4.78% | 59.68% | |
64 Neutral | $10.64B | 16.04 | 5.48% | 2.12% | 2.74% | -23.62% |